Replimune Group (REPL)
(Delayed Data from NSDQ)
$6.42 USD
+0.27 (4.39%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $6.41 -0.01 (-0.16%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum F VGM
Income Statements
Fiscal Year end for Replimune Group, Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | NA | 0 | 0 | 0 | 0 |
Cost Of Goods | NA | 0 | 0 | 0 | 0 |
Gross Profit | NA | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 177 | 118 | 80 | 56 |
Income After Depreciation & Amortization | 0 | -177 | -118 | -80 | -56 |
Non-Operating Income | NA | 7 | 3 | 2 | 5 |
Interest Expense | NA | 4 | 2 | 3 | 2 |
Pretax Income | NA | -174 | -118 | -81 | -53 |
Income Taxes | NA | 0 | 0 | 0 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -174 | -118 | -81 | -53 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -174 | -118 | -81 | -53 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -180 | -114 | -77 | -57 |
Depreciation & Amortization (Cash Flow) | NA | -3 | 4 | 3 | 0 |
Income After Depreciation & Amortization | 0 | -177 | -118 | -80 | -56 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | NA | 58.21 | 52.21 | 46.25 | 34.26 |
Diluted EPS Before Non-Recurring Items | NA | -2.99 | -2.26 | -1.75 | -1.54 |
Diluted Net EPS (GAAP) | NA | -2.99 | -2.26 | -1.75 | -1.54 |
Fiscal Year end for Replimune Group, Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 56.54 | 63.83 | 55.65 | 52.99 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -56.54 | -63.83 | -55.65 | -52.99 |
Non-Operating Income | NA | 7.45 | 5.08 | 7.95 | 5.61 |
Interest Expense | NA | 1.55 | 1.50 | 1.66 | 1.57 |
Pretax Income | NA | -50.65 | -60.25 | -49.35 | -48.95 |
Income Taxes | NA | 0.47 | -0.20 | 0.20 | 0.29 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -51.12 | -60.04 | -49.56 | -49.24 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -51.12 | -60.04 | -49.56 | -49.24 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 66.65 | 66.58 | 66.37 | 66.54 |
Diluted EPS Before Non-Recurring Items | NA | -0.77 | -0.90 | -0.75 | -0.74 |
Diluted Net EPS (GAAP) | NA | -0.77 | -0.90 | -0.75 | -0.73 |